These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 35178049)

  • 21. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
    Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
    Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TREM2 receptor protects against complement-mediated synaptic loss by binding to complement C1q during neurodegeneration.
    Zhong L; Sheng X; Wang W; Li Y; Zhuo R; Wang K; Zhang L; Hu DD; Hong Y; Chen L; Rao H; Li T; Chen M; Lin Z; Zhang YW; Wang X; Yan XX; Chen X; Bu G; Chen XF
    Immunity; 2023 Aug; 56(8):1794-1808.e8. PubMed ID: 37442133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration.
    Zhou J; Wade SD; Graykowski D; Xiao MF; Zhao B; Giannini LAA; Hanson JE; van Swieten JC; Sheng M; Worley PF; Dejanovic B
    Sci Transl Med; 2023 Mar; 15(689):eadf0141. PubMed ID: 36989373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ceftriaxone ameliorates hippocampal synapse loss by inhibiting microglial/macrophages activation in glial glutamate transporter-1 dependent manner in the APP/PS1 mouse model of Alzheimer's disease.
    Liu LZ; Fan SJ; Gao JX; Li WB; Xian XH
    Brain Res Bull; 2023 Aug; 200():110683. PubMed ID: 37301482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial senescence alleviates cognitive impairment in a mouse model of Alzheimer's disease.
    Horibe S; Emoto T; Mizoguchi T; Tanaka T; Kawauchi S; Sasaki N; Yamashita T; Ikeda K; Emoto N; Hirata KI; Rikitake Y
    Glia; 2024 Jan; 72(1):51-68. PubMed ID: 37610154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of microglial SIRPα promotes synaptic pruning in preclinical models of neurodegeneration.
    Ding X; Wang J; Huang M; Chen Z; Liu J; Zhang Q; Zhang C; Xiang Y; Zen K; Li L
    Nat Commun; 2021 Apr; 12(1):2030. PubMed ID: 33795678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement and microglia mediate early synapse loss in Alzheimer mouse models.
    Hong S; Beja-Glasser VF; Nfonoyim BM; Frouin A; Li S; Ramakrishnan S; Merry KM; Shi Q; Rosenthal A; Barres BA; Lemere CA; Selkoe DJ; Stevens B
    Science; 2016 May; 352(6286):712-716. PubMed ID: 27033548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. hTERT Peptide Fragment GV1001 Prevents the Development of
    Chen W; Kim SY; Lee A; Kim YJ; Chang C; Ton-That H; Kim R; Kim S; Park NH
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment in Alzheimer's disease FAD
    Zhang C; Qi H; Jia D; Zhao J; Xu C; Liu J; Cui Y; Zhang J; Wang M; Chen M; Tang B
    Life Sci; 2024 Mar; 340():122457. PubMed ID: 38266812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aerobic exercise regulates GPR81 signal pathway and mediates complement- microglia axis homeostasis on synaptic protection in the early stage of Alzheimer's disease.
    Yang J; Yuan S; Jian Y; Lei Y; Hu Z; Yang Q; Yan X; Zheng L; Li J; Liu W
    Life Sci; 2023 Oct; 331():122042. PubMed ID: 37634815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microglial Trem2 induces synaptic impairment at early stage and prevents amyloidosis at late stage in APP/PS1 mice.
    Sheng L; Chen M; Cai K; Song Y; Yu D; Zhang H; Xu G
    FASEB J; 2019 Sep; 33(9):10425-10442. PubMed ID: 31219699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-132 regulates the expression of synaptic proteins in APP/PS1 transgenic mice through C1q.
    Xu N; Li AD; Ji LL; Ye Y; Wang ZY; Tong L
    Eur J Histochem; 2019 May; 63(2):. PubMed ID: 31060348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic mitochondrial dysfunction and septin accumulation are linked to complement-mediated synapse loss in an Alzheimer's disease animal model.
    Györffy BA; Tóth V; Török G; Gulyássy P; Kovács RÁ; Vadászi H; Micsonai A; Tóth ME; Sántha M; Homolya L; Drahos L; Juhász G; Kékesi KA; Kardos J
    Cell Mol Life Sci; 2020 Dec; 77(24):5243-5258. PubMed ID: 32034429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglial cathepsin E plays a role in neuroinflammation and amyloid β production in Alzheimer's disease.
    Xie Z; Meng J; Kong W; Wu Z; Lan F; Narengaowa ; Hayashi Y; Yang Q; Bai Z; Nakanishi H; Qing H; Ni J
    Aging Cell; 2022 Mar; 21(3):e13565. PubMed ID: 35181976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron accumulation in microglia triggers a cascade of events that leads to altered metabolism and compromised function in APP/PS1 mice.
    McIntosh A; Mela V; Harty C; Minogue AM; Costello DA; Kerskens C; Lynch MA
    Brain Pathol; 2019 Sep; 29(5):606-621. PubMed ID: 30661261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune proteins C1q and CD47 may contribute to aberrant microglia-mediated synapse loss in the aging monkey brain that is associated with cognitive impairment.
    DeVries SA; Conner B; Dimovasili C; Moore TL; Medalla M; Mortazavi F; Rosene DL
    Geroscience; 2024 Apr; 46(2):2503-2519. PubMed ID: 37989825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
    Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
    Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q.
    Spurrier J; Nicholson L; Fang XT; Stoner AJ; Toyonaga T; Holden D; Siegert TR; Laird W; Allnutt MA; Chiasseu M; Brody AH; Takahashi H; Nies SH; Pérez-Cañamás A; Sadasivam P; Lee S; Li S; Zhang L; Huang YH; Carson RE; Cai Z; Strittmatter SM
    Sci Transl Med; 2022 Jun; 14(647):eabi8593. PubMed ID: 35648810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease.
    Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM
    BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.